Home

Screening

Bipolar, Schizophrenia

Read time: 5 min

Congress highlights

Exploring the transmission of mental illness from parents to children

A family history of severe mental illness (SMI) is a known risk factor for the development of SMI...

Bipolar, Schizophrenia

Read time: 3 min

Congress highlights

Can neuroimaging lead to the development of biomarkers in schizophrenia?

Schizophrenia presents differently in different patients, yet due to a lack of objective means to...

Bipolar, Schizophrenia

Read time: 3 min

Congress highlights

Debate continues on impact of duration of untreated psychosis on outcomes in psychosis

Duration of untreated psychosis (DUP) is defined as the time from manifestation of the first...

Bipolar, Schizophrenia

Read time: 5 min

Congress highlights

Poor Heart Health Outcomes in Patients with Mental Illness

Patients living with serious mental illnesses (SMI) have high rates of cardiovascular morbidity and...

Bipolar, Schizophrenia

Read time: 2 min

Congress highlights

The Double Burden of Diabetes and Severe Mental Illness

Although antipsychotics are the mainstay of treatment in severe mental illness (SMI), their use is...

Read time: 3 min

Congress highlights

Videogames and Psychosis: Concerns versus Opportunities

The Schizophrenia International Research Society (SIRS) 2023 congress hosted academics and the...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country